A Final Resolution Following Years of Polypharmacy. Read more about A Final Resolution Following Years of Polypharmacy.
Insulin Degludec, an alternative to Insulin U500, in severe insulin resistance due to antibodies. Read more about Insulin Degludec, an alternative to Insulin U500, in severe insulin resistance due to antibodies.
Experience of Tresiba at Guy's and St Thomas' Hospital. Read more about Experience of Tresiba at Guy's and St Thomas' Hospital.
Best in class insulin prescription charts. Read more about Best in class insulin prescription charts.
Diabetes Mellitus, Statins and devastating myopathy. Read more about Diabetes Mellitus, Statins and devastating myopathy.
Urinary Proteomics for Diagnosis of Nephropathy and Subclinical Vascular Damage in Type 2 Diabetes. Read more about Urinary Proteomics for Diagnosis of Nephropathy and Subclinical Vascular Damage in Type 2 Diabetes.
Stress Hyperglycaemia in Hospitalised Patients and Their 3-Year Risk of Diabetes: A Scottish Retrospective Cohort Study. Read more about Stress Hyperglycaemia in Hospitalised Patients and Their 3-Year Risk of Diabetes: A Scottish Retrospective Cohort Study.
The burden and development of clinically significant chronic liver disease in older people with type 2 diabetes: The Edinburgh Type 2 Diabetes Study. Read more about The burden and development of clinically significant chronic liver disease in older people with type 2 diabetes: The Edinburgh Type 2 Diabetes Study.
Role of Urine C-Peptide Creatinine ratio in the management of Diabetes. Read more about Role of Urine C-Peptide Creatinine ratio in the management of Diabetes.
Early ‘real world’ data on dapagliflozin: effective glucose control, blood pressure reduction, weight loss and reduced medication burden. Read more about Early ‘real world’ data on dapagliflozin: effective glucose control, blood pressure reduction, weight loss and reduced medication burden.
